
Hodgkin lymphoma Program in Pharmaceutical Benefits Scheme (PBS) 012-18042700

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority, see Processing
Written Authority Required Listings. Contact a Program Support Officer
(PSO) if unsure on how to action an application.

Relapsed or refractory Hodgkin lymphoma quick reference

Drugs listed:

-   brentuximab vedotin
-   pembrolizumab

The below table is created as a quick reference when confirming what
section/who administers the program and whether a PA is required and
where it is to be processed.

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | Adm       | PA        | Database  | Online    |
| trictions | Level and | inistered | A         |           | Au        |
|           | Section   | by        | ssessment |           | thorities |
|           |           |           |           |           | System    |
|           |           |           |           |           | (OPA) or  |
|           |           |           |           |           | Mainframe |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | PBS –     | No        | No        | OPA       |
| pemb      |           | Complex   |           |           |           |
| rolizumab | -   S100  | Drugs     |           |           |           |
| – PB232   |     EFC   | Program   |           |           |           |
|           |           |           |           |           |           |
| Initial   | pemb      |           |           |           |           |
| br        | rolizumab |           |           |           |           |
| entuximab |           |           |           |           |           |
| vedotin   | -   S100  |           |           |           |           |
| (ASCT     |     EFC   |           |           |           |           |
| naïve or  |           |           |           |           |           |
| failure)  | br        |           |           |           |           |
| – PB205   | entuximab |           |           |           |           |
|           | vedotin   |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | Te        | PBS –     | No        | No        | OPA       |
| ontinuing | lephone/E | Complex   |           |           |           |
|           | lectronic | Drugs     |           |           |           |
|           |           | Program   |           |           |           |
|           | -   S100  |           |           |           |           |
|           |     EFC   |           |           |           |           |
|           |           |           |           |           |           |
|           | br        |           |           |           |           |
|           | entuximab |           |           |           |           |
|           | vedotin   |           |           |           |           |
|           |           |           |           |           |           |
|           | -   S100  |           |           |           |           |
|           |     EFC   |           |           |           |           |
|           |           |           |           |           |           |
|           | Pemb      |           |           |           |           |
|           | rolizumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

                                   

-   Services Australia ABN 90 794 605 008 
